Golden
F2 Ventures

F2 Ventures

A venture capital and private equity firm focused on investing in the biotechnology sector.

F2 Ventures is a venture capital and private equity firm focused on investing in the biotechnology sector that was founded in 2002 and is headquartered in London, England. F2 Ventures also has an office in Geneva, Switzerland.



Investments

Notable investments made by F2 Venture partners include; AlloVir (series A and series B), TCR2 (series B), Cullinan Oncology (series A), iPrice Group (seed round), Clinical Link (venture round), Chiasma (sereis E), ProterixBio (sereis C and series D), and Chiasma (series C). 



Timeline

Funded Companies

3 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.

TriNetX is a Cambridge, Massachusetts-based company.

Cullinan Oncology is a Cambridge, Massachusetts-based company.

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References